what is AIHA
- User
what is AIHA
- Assistant
AIHA = Auto-Immune Hemolytic Anemia
Auto-immune hemolytic anemia is a disorder in which your own immune system mistakenly attacks and destroys your red blood cells (RBCs) faster than your bone marrow can replace them. Fewer healthy RBCs → less oxygen delivered to tissues → anemia-related symptoms.
Quick Facts
Feature Details Full name Auto-Immune Hemolytic Anemia Incidence ~1–3 cases per 100 000 people per year (rare) Key problem Antibodies (IgG or IgM) bind to RBCs → destruction in spleen, liver, or circulation Typical onset Any age; peaks in young women (warm type) & elderly men (cold type) Treatable? Yes – response varies, but many patients do well with therapy
Why does the immune system attack RBCs?
- Primary (idiopathic) – no other disease found (≈50% of cases).
- Secondary – linked to:
• Auto-immune diseases (e.g., SLE, rheumatoid arthritis)
• Lymphoid cancers (CLL, lymphoma)
• Infections (Mycoplasma, EBV, HIV, COVID-19)
• Certain drugs (penicillin, cephalosporins, methyldopa, NSAIDs)
• Post-transplant, immune dysregulation, etc.
Types of AIHA
Type Antibody Optimal temp Mechanism Typical associations Warm AIHA IgG 37 °C (body temp) RBCs opsonized → removed by splenic macrophages (extravascular hemolysis) SLE, CLL, drugs Cold Agglutinin Disease (CAD) IgM 0–4 °C (may act up to 30 °C) IgM + complement → RBC destruction (mainly liver) Mycoplasma, EBV, lymphomas Paroxysmal Cold Hemoglobinuria (rare) “Donath-Landsteiner” IgG Biphasic: binds cold, lyses warm Intravascular hemolysis Post-viral in kids Mixed/Other Both IgG & IgM — Combination Rare
Common Signs & Symptoms
• Fatigue, weakness, pallor 🤍
• Shortness of breath, rapid heartbeat
• Jaundice (yellow skin/eyes) & dark urine (from free hemoglobin)
• Splenomegaly (enlarged spleen)
• For cold AIHA: painful blue fingers/ears (acrocyanosis) in the cold
How is it diagnosed?
- CBC: anemia with ↑ reticulocyte count
- Blood smear: spherocytes (warm AIHA), agglutination (cold)
- Elevated LDH, indirect bilirubin; ↓ haptoglobin
- Direct Antiglobulin Test (DAT, “Coombs” test) – detects antibodies/complement on RBCs
- If DAT-negative but suspicion high: use more sensitive techniques (flow cytometry, eluates)
- Screen for underlying causes: autoimmune panels, infection serologies, imaging for lymphoma, etc.
Treatment Overview
Warm AIHA
- First-line: Corticosteroids (prednisone 1 mg/kg) → taper over weeks.
- Second-line: Rituximab (anti-CD20), splenectomy, immunosuppressants (azathioprine, cyclosporine, mycophenolate).
- Supportive: Folic acid, transfusions (cross-matching may be challenging but doable).
Cold Agglutinin Disease
- Keep warm (avoid cold exposure).
- Rituximab ± bendamustine is main pharmacologic therapy.
- Plasmapheresis for acute crises; complement inhibitors (sutimlimab) now emerging.
- Steroids usually less effective.
Acute severe hemolysis (any type)
• Hospitalize, give high-dose IV steroids, possible IVIG, transfuse PRBCs, treat trigger.Paroxysmal Cold Hemoglobinuria
• Usually self-limited; supportive care + avoid cold.
Prognosis
• Many patients respond to steroids or rituximab within weeks.
• Relapses are common; some need long-term maintenance.
• Mortality is low in specialized care but linked to underlying disorders (e.g., lymphoma).
When to see a doctor urgently?
• Sudden dark/bloody urine, yellowing skin/eyes
• Rapid worsening of fatigue or shortness of breath
• Cold-induced painful fingers/ears
• Fever, night sweats, weight loss (could point to lymphoma)
Bottom line
AIHA is a rare but treatable autoimmune condition where antibodies destroy red blood cells. Early recognition, identification of the type (warm vs. cold), and prompt therapy (often steroids or rituximab) can reverse anemia and minimize complications. If you suspect AIHA, seek medical evaluation and hematology referral.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.